press release

Jan. 13, 2021, 8:42 a.m. EST

Opioid Use Disorder Market Worth USD 4.87 Billion at 8.7% CAGR by 2027 Backed by Increasing Number of Opioid Dependence Patients in North America

Key Prominent Players Covered in the Opioid Use Disorder Market Research Report Are Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt, Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, Camurus Ltd. and other key market players.

Pune, India, Jan 13, 2021 (GLOBE NEWSWIRE via COMTEX) -- Pune, India, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The global opioid use disorder market is expected to experience exponential growth by reaching USD 4.87 billion by 2027 while exhibiting a CAGR of 8.7% between 2020 and 2027. The growth is attributable to the increasing focus by the government agencies to promote opioid use disorder treatments and the growing adoption of buprenorphine treatment patches across the globe. Fortune Business Insights published this information in its latest report. The report further observes that the market stood at USD 2.81 billion in 2019.

Opioids are powerful and effective painkillers that are used to alleviate pain caused by chronic diseases. They are highly addictive and can lead to over-dependence on them leading to severe health implications. The addiction to opioids can lead to fatal consequences that may even lead to death.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/opioid-use-disorder-oud-market-102674

Increasing Government Focus to Create Awareness to Promote Growth

In 2017, the United States Department of Health & Human Services (HHS) declared the opioid crisis as a public health emergency. Since then, the government of several countries have actively focused on creating awareness regarding opioid use disorder treatments for the patients suffering from opioid dependency. Nowadays, buprenorphine treatment patches are adopted extensively that aid in significant reduction of pain and can be self-administered by the patient. These factors are likely to boost the global opioid use disorder market growth in the forthcoming years.

Buprenorphine Segment Held 81.1% Market Share in 2019

The buprenorphine segment, based on drug class, is expected to showcase considerable growth backed by the growing adoption of drugs that contain buprenorphine in developed countries such as the United States and France. The segment held a market share of about 81.1% in 2019.

Increasing Focus on COVID-19 Patients to Hamper Market Growth Prospects

The global pandemic has led to a massive shift in the healthcare sector. More precedence has been given to treating COVID-19 patients while other non-COVID procedures have either been halted or postponed. This is likely to hamper the growth prospects of the market. In 2018, around 128 people died due to opioid overdose and the novel coronavirus has brought forth several challenges to treat the disorder. To mitigate the adverse effect, the governments are taking efforts to address the issues of the people suffering from the disorder. Therefore, the introduction of telehealth treatment is expected to favor the market growth in the forthcoming years.

Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/opioid-use-disorder-oud-market-102674

North America to Remain at Forefront; Increasing Number of Patients Suffering from Opioid Dependency to Aid Growth

Among all the regions, North America is expected to remain dominant and hold the highest position in the global opioid use disorder market in the forthcoming years. The dominance is attributable to the increasing number of patients suffering from opioid dependence implications in the region between 2020 and 2027. The region stood at USD 2.16 billion in 2019.

On the other hand, Europe is expected to hold the second position in the market in the forthcoming years. This is ascribable to the increasing number of launches of opioid use disorder treatment solutions in the region between 2020 and 2027.

Major Players Focus on Partnership to Intensify Industry Competition

The global opioid use disorder market is experiencing a healthy competition between major players that are striving to maintain their dominance. The companies are partnering with other players to expand their opioid use disorder treatment solutions and further boost their positions. Moreover, the adoption of strategies such as merger and acquisition, collaboration, and facility expansion by other players is likely to boost the market growth during the forecast period.

Quick Buy - Opioid Use Disorder Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102674

Industry Development:

  • August 2019: Orexo AB announced its partnership with GAIA AG to develop and commercialize a new digital therapy for treating opioid use disorder in patients. The partnership is aimed at consolidating their positions in the highly competitive global marketplace.

List of the Companies Profiled in the Global Market for Opioid Use Disorder:

  • Indivior PLC (Chesterfield, U.S.)

  • Alkermes (Dublin, Ireland)

  • Orexo AB (Uppsala, Sweden)

  • Titan Pharmaceuticals, Inc. (South San Francisco, U.S.)

  • Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel)

  • Mallinckrodt Pharmaceuticals (Staines-Upon-Thames, U.K.)

  • BioDelivery Sciences International Inc. (Raleigh, U.S.)

  • Viatris Inc. (Mylan N.V.) (Canonsburg, U.S.)

  • Pfizer, Inc. (New York City, U.S.)

  • Hikma Pharmaceuticals PLC (London, U.K.)

  • Camurus (Lund, Sweden)

  • Other Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/opioid-use-disorder-oud-market-102674

Table of Contents:

  • Introduction

  • Executive Summary

  • Market Dynamics

  • Key Insights

  • Global Opioid Use Disorder Market Analysis, Insights and Forecast, 2016-2027

TOC Continued....!

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/opioid-use-disorder-oud-market-102674

SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies

  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.

  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility

  • Number of procedures and average price of procedures

  • Replacement rate and pricing of capital equipment

  • Market dynamics in relation to the market under focus - Drivers, restraints, trends, and opportunities

  • Market & technological trends, new product developments, product pipeline.

Have a Look at Related Reports:

Disposable Medical Gloves Market Share & Industry Analysis, By Application (Surgical and Examination), By Material (Latex and Synthetic), By Category (Powdered and Powder free) By End User (Hospitals & Clinics, Diagnostic/Pathology Labs, and Others), and Regional Forecast 2019-2026

Medical Transcription Software Market Share & Industry Analysis, By Deployment (Cloud/Web-Based and Installed/On-Premises), By End User Facility (Hospitals, Diagnostic Centers, Clinics, and Others), By Type (Voice Capture and Voice Recognition), By End User (Radiologists, Surgeons, Clinicians, and Others), and Regional Forecast 2019-2026

Bovine Lactoferrin Market Share Trends & Industry Analysis, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and Regional Forecast, 2019-2026

Knee Replacement Market Share & Industry Analysis, By Procedure (Total Knee Arthroplasty, Partial Knee Arthroplasty, and Revision Arthroplasty) By Implant Type (Fixed Bearing, Mobile Bearing, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026

Electrophysiology Devices Market Share & Industry Analysis, By Type (Ablation Catheters, Diagnostic Catheters, Mapping Systems, Accessories & Others), By Application (Atrial Fibrillation, Supraventricular Tachycardia (SVT), Ventricular Tachycardia, and Others), By End User (Hospitals & ASCs, and Specialty Clinics & Diagnostic Centers), and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights(TM)
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/opioid-use-disorder-oud-market-9810

COMTEX_377617292/2471/2021-01-13T08:41:37

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

(C) Copyright 2021 GlobeNewswire, Inc. All rights reserved.

Partner Center

Link to MarketWatch's Slice.